Melinta Therapeutics, Inc. (NASDAQ:MLNT)

12.85
Delayed Data
As of 4:00pm ET
 -0.15 / -1.15%
Today’s Change
10.25
Today|||52-Week Range
24.25
-18.67%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Melinta Therapeutics, Inc. have a median target of 18.00, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +40.08% increase from the last price of 12.85.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Melinta Therapeutics, Inc.. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.86
Sales
$2.8M
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.13%
 
 
 
 
 
 
Growthannually 60.09%
 
 
 
 
 
 

Sales

Growthquarterly 65.87%
 
 
 
 
 
 
Growthannually -43.06%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.